Risk factors for drug-resistant epilepsy in adult patients Factores de riesgo de epilepsia farmacorresistente en pacientes adultos

LAGGER, IGNACIO; GARINO, ELIANA; MARTINEZ, OSCAR; KNORRE, EDUARDO; ERNST, GLENDA; BURGUEÑO, ADRIANA LAURA

MEDICINA CLINICA

EDICIONES DOYMA S A

Año: 2023 vol. 160 p. 547 - 550

0025-7753

Introduction: Drug-resistant epilepsy occurs in about 30% of epilepsy patients. It has been suggested that etiology or seizure type would increase the risk of pharmacoresistance. This study aims to compare the characteristics of patients with drug-sensitive epilepsy with patients with drug-resistant epilepsy to identify risk factors. Patient and methods: A multicentric cohort study was conducted between 2019 and 2022. We included patients >18 years-old with epilepsy but excluded psychogenic non-epileptic seizures and less than 2 years of follow-up. Results: We included 128 patients, of whom 46 had drug-resistance epilepsy, and 82 responding to medication. Both groups showed similar characteristics. Febrile seizures (OR: 7.25), focal epilepsy (OR: 2.4), focal seizures with loss of consciousness (OR: 2.36), structural etiology (OR: 2.2) and abnormal MRI (OR: 4.6) were significant risk factors for drug-resistance epilepsy. Conclusion: Following other studies, we observed that factors such as epilepsy type, seizure type, structural etiology, abnormal MRI, and febrile seizure increased the risk for drug-resistance epilepsy, in our population.